Services Design Development Scientific Advice Project Management QA – Quality Assurance Monitoring Clinical Performance Data Management/eTrials Biostatistics Medical Writing Expert Statement Expertise Pharmacokinetics BA/BE Interactions Oncological trials Ophthalmological trials Inhalatives Transdermal Therapeutic Systems Children Sexual Hormones Therapeutic Expertise Clinical Development Phase I Phase II / Proof of Concept Phase III in OTC Phase III Non-Interventional Magnetic Marker Monitoring Medical Devices Nutrition Studies Clinical Pharmacology Unit Location Plan Capacity Technical Monitoring Ophthalmology Gynaecology Intensive Assessment Unit Clean Room Area Archive About Us Goals and Visions Our Experts Science Quality Library Presentations Library Publications Locations Career News 3rd GBHI in Amsterdam: lively discussions and intensive exchange with authorities Meet us in Amsterdam: 3rd GBHI Conference starts soon (12 – 13 April 2018) Meet us in Munich: AGAH Annual Meeting 26 – 27 April 2018 Regorafenib: first in human as eye drops 3rd GBHI conference – all speakers confirmed 1st GBHI-Conference – Conference Report now available Probanden The SocraTec Family SocraTec C&S SocraMetrics Cooperations
Contraception Source Data Verification Early phase Pharmacokintetics Rhine Main area Oncologic network Dry eye Experience DFI Non interventional Ophthalmological trials GCP Common cold Monitoring Macular CRA Standard operating procedure IB Bioequivalence Cough Inspection Sequential designs Sore throat Phase IV Degeneration Bioavailability Quality Absorption windows Immunogenicity Hypothalamic PASS Expert AGAH CRO HRT Cardiovascular surveillance Uveitis Lung Safety Creativity Oncology In vitro in vivo correlation Clinical Monitoring Ophthalmology Transdermal therapeutic system Phase I Unit NIS ADAM Statistical programming Phase I Endpoint First in human DPI Glaucoma Copyright Patient recruitment Eye disease CDISC Pharmacodynamic studies Biosimilars Standardisation Auditing Informed Consent Procedure Scientific advice WinNonlin SDV SOP based GLP Investigators brochure Patients Gynaecological trials Pilot study Hormone replacement therapy Sample size estimation Design development Project Management TTS Local tolerability EMA GCP training CDM HPA axis Data management Efficacy Pharmacology Children Biopharmaceutics HTA Intensive assessment station Protocol FIM Phase IIb trials MDI Life cycle management Patch Consultancy IMPD Biometrics Pulse oximetry plethysmography Referral system Pragmatism IVIVC Clinical pharmacology unit Dermal irritation Sensitisation trials SAS Paediatricians Quality Assurance Axis Anaesthesiologist Xerostomia DUS Statistical Analysis Plan Centralised procedure Spacious archive Pituitary Postmenopausal women FDA CDASH Adrenocortical Clinical study Drug Food Interaction Clinical trials Ovulation inhibition Protocol development Dry powder inhaler Allergy IEC Pharmacokinetics Data Validation Plan SocraTec C&S Inhalatives Biopharmaceutical Absorption CDSIC Edema Central surveillance system Competence Slit lamp microscopy Highly variable drugs Feasibility Charcoal Post authorisation Statistical services Ophthalmologist Phase IIa trials Audit Drug Drug Interaction DDI MCID Oncological patients CRF Authorities PAES Product development Metered dose inhaler Healthy subjects Training OTC Scientific expertise COPD Quality Management System ICF Subcontractor qualification Phase III Recruitment rates US CFR 21 Part 11 Legal Information Patch adhesion Phase II Legal representative Clinical development program Thuringia Asthma Database Good Clinical Practice Network US FDA MMM ANVISA Ocular tolerability Steady state Elpro Female adolescents Dose linearity Data Management Plan  
 
Menu

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
All fine on front page